Amplifying the antidiabetic actions of glucagon-like peptide-1: Potential benefits of new adjunct therapies. Tanday N, Flatt PR, Irwin N. Diabet Med 2021;38:e14699.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tanday N, Flatt PR, Irwin N. Amplifying the antidiabetic actions of glucagon-like peptide-1: Potential benefits of new adjunct therapies. Diabet Med 2021;38:e14699.
PMID: 34562330